This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Transthera Sciences (Nanjing), Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Zejuan Sheng
Introduction
Zejuan Sheng is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of medicine, particularly in the treatment of heart failure diseases. His innovative work has led to the development of a unique compound that shows promise in improving heart function.
Latest Patents
Zejuan Sheng holds a patent for the "Uses of phosphodiesterase inhibitors." This patent discloses the uses of a compound represented by a general formula and its pharmaceutically acceptable salts, isomers, and deuterated compounds. The compound has been proven through experiments to improve heart function in rats suffering from heart failure. It also reverses myocardial remodeling caused by heart failure and reduces fibrosis in the marginal zone of infarction. This patent highlights the potential of his invention in the medical field.
Career Highlights
Zejuan Sheng is currently associated with Transthera Sciences (Nanjing), Inc. His work at this company focuses on advancing research and development in pharmaceuticals. His dedication to innovation has positioned him as a key figure in the industry.
Collaborations
One of his notable coworkers is Frank Wu. Together, they contribute to the ongoing research and development efforts at Transthera Sciences.
Conclusion
Zejuan Sheng's innovative work in the field of heart failure treatment showcases his commitment to improving medical outcomes. His patent and contributions to Transthera Sciences reflect his significant impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile